Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies-Reference-Cited by-同舟云学术

Three doses of COVID-19 vaccines in multiple sclerosis patients treated with disease-modifying therapies

Published:2022-12 Issue: Volume:68 Page:104119
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Baba Cavid,Ozcelik Sinem,Kaya Ergi,Samedzada Ulvi,Ozdogar Asiye Tuba^ORCID,Cevik Sumeyye,Dogan Yavuz,Ozakbas Serkan

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference16 articles.

1. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021

2. Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis;Bar-Or;Neurology,2020

3. Impact of vaccination on the COVID-19 pandemic in U.S. states;Chen;Sci. Rep.,2022

4. Long-term immunological changes in azathioprine-treated MS patients;Corsini;Neurol. Sci.,2000

5. A systematic review of SARS-CoV-2 vaccine candidates;Dong;Signal Transduct. Target. Ther.,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine response in people with multiple sclerosis treated with fumarates;Multiple Sclerosis Journal - Experimental, Translational and Clinical;2023-07

2. Three Doses of COVID-19 Vaccines: A Retrospective Study Evaluating the Safety and the Immune Response in Patients with Multiple Sclerosis;Journal of Clinical Medicine;2023-06-23

3. Dynamic Evolution of Humoral and T-Cell Specific Immune Response to COVID-19 mRNA Vaccine in Patients with Multiple Sclerosis Followed until the Booster Dose;International Journal of Molecular Sciences;2023-05-10